Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1. (2021)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bcp.2021.114656
PubMed Identifier: 34129856
Publication URI: http://europepmc.org/abstract/MED/34129856
Type: Journal Article/Review
Volume: 190
Parent Publication: Biochemical pharmacology
ISSN: 0006-2952